buthionine sulfoximine has been researched along with Kidney Diseases in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (11.76) | 18.7374 |
| 1990's | 9 (52.94) | 18.2507 |
| 2000's | 5 (29.41) | 29.6817 |
| 2010's | 1 (5.88) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmad, SF; Al-Harbi, MM; Al-Harbi, NO; Alotaibi, MR; AlSaad, AM; Ansari, MA; Nadeem, A | 1 |
| Li, J; Sun, W; Xu, Z; Yang, J; Yin, Z; Yu, J | 1 |
| Cohen, SD; Dominick, PK; Roberts, JC; Slitt, AM | 1 |
| Jia-Ming, Y; Jing-Hua, Y; Zhao-Fa, X; Zhong-Wei, Y | 1 |
| Anand, SS; Latendresse, JR; Mehendale, HM; Mumtaz, MM; Palkar, PS; Philip, BK | 1 |
| Brandt, I; Brittebo, EB; Darnerud, PO; Eriksson, C | 1 |
| Eger, EI; Kandel, L; Kerschmann, RL; Laster, MJ; Martin, JL; Reed, GF | 1 |
| Mizutani, T; Murakami, M; Nakanishi, K; Suzuki, K; Yoshida, K | 1 |
| Hanada, K; Mukasa, Y; Nomizo, Y; Ogata, H | 1 |
| Bonner, FW; Eason, CT; Gartland, KP; Nicholson, JK | 1 |
| Anderson, ME; Meister, A; Naganuma, A | 1 |
| Ishikawa, M; Sasaki, K; Takayanagi, Y | 2 |
| Ito, K; Mizutani, T; Nakanishi, K; Nomura, H | 1 |
| Brown, PI; Nicoll, DW; Rankin, GO; Teets, VJ | 1 |
| Cockett, AT; Lee, KE; Mayer, RD | 1 |
| Nakagawa, Y; Tayama, K | 1 |
17 other study(ies) available for buthionine sulfoximine and Kidney Diseases
| Article | Year |
|---|---|
Psoriasis-like inflammation leads to renal dysfunction via upregulation of NADPH oxidases and inducible nitric oxide synthase.
Topics: Acetylcysteine; Aminoquinolines; Animals; Antioxidants; Buthionine Sulfoximine; Disease Models, Animal; Humans; Imiquimod; Inflammation; Kidney; Kidney Diseases; Male; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; NADPH Oxidase 2; NADPH Oxidase 4; NADPH Oxidases; Nitric Oxide Synthase Type II; Oxidative Stress; Psoriasis | 2017 |
Effects of BSO, GSH, Vit-C and DMPS on the nephrotoxicity of mercury.
Topics: Animals; Antioxidants; Ascorbic Acid; Buthionine Sulfoximine; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Female; Glutathione; Kidney Cortex; Kidney Diseases; Liver; Male; Mercuric Chloride; Mercury Poisoning; Rats; Rats, Wistar; Unithiol | 2007 |
Effect of ribose cysteine pretreatment on hepatic and renal acetaminophen metabolite formation and glutathione depletion.
Topics: Acetaminophen; Animals; Blood Urea Nitrogen; Buthionine Sulfoximine; Chemical and Drug Induced Liver Injury; Cysteine; Glutathione; In Vitro Techniques; Kidney; Kidney Diseases; L-Iditol 2-Dehydrogenase; Liver; Liver Diseases; Male; Mice; Mice, Inbred Strains; Microsomes, Liver; Prodrugs; Protective Agents; Thiazoles; Thiazolidines | 2005 |
[Experimental study on the effects of BSO, GSH, vitamin C and DMPS on the nephrotoxicity induced by mercury].
Topics: Animals; Antioxidants; Ascorbic Acid; Buthionine Sulfoximine; Dose-Response Relationship, Drug; Female; Glutathione; Kidney Cortex; Kidney Diseases; Male; Mercuric Chloride; Mercury Poisoning; Random Allocation; Rats; Rats, Wistar; Unithiol | 2005 |
Subchronic chloroform priming protects mice from a subsequently administered lethal dose of chloroform.
Topics: Alanine Transaminase; Animals; Area Under Curve; Buthionine Sulfoximine; Chemical and Drug Induced Liver Injury; Chloroform; Cytochrome P-450 CYP2E1; Dose-Response Relationship, Drug; Drug Tolerance; Glutathione; Glutathione Reductase; Hepatocytes; Intubation, Gastrointestinal; Kidney; Kidney Diseases; Liver Diseases; Mice; Survival Rate | 2006 |
Nephrotoxicity and covalent binding of 1,1-dichloroethylene in buthionine sulphoximine-treated mice.
Topics: Animals; Autoradiography; Binding Sites; Buthionine Sulfoximine; Dichloroethylenes; Female; Kidney Diseases; Kidney Tubules, Proximal; Liver; Male; Methionine Sulfoximine; Mice; Mice, Inbred C57BL; Nasal Mucosa | 1993 |
Metabolism of compound A by renal cysteine-S-conjugate beta-lyase is not the mechanism of compound A-induced renal injury in the rat.
Topics: Aminooxyacetic Acid; Anesthetics, Inhalation; Animals; Buthionine Sulfoximine; Carbon-Sulfur Lyases; Enzyme Inhibitors; Ethers; Glutathione; Hydrocarbons, Fluorinated; Isoxazoles; Kidney; Kidney Diseases; Lyases; Male; Methionine Sulfoximine; Methyl Ethers; Rats; Rats, Wistar; Sevoflurane | 1996 |
Nephrotoxicity of thioformamide, a proximate toxicant of nephrotoxic thiazoles, in mice depleted of glutathione.
Topics: Animals; Buthionine Sulfoximine; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Female; Formamides; Glutathione; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred ICR; Sex Factors | 1996 |
Effect of buthionine sulphoximine, glutathione and methimazole on the renal disposition of cisplatin and on cisplatin-induced nephrotoxicity in rats: pharmacokinetic-toxicodynamic analysis.
Topics: Animals; Antineoplastic Agents; Area Under Curve; Blood Urea Nitrogen; Buthionine Sulfoximine; Cisplatin; Glomerular Filtration Rate; Glutathione; In Vitro Techniques; Kidney; Kidney Cortex; Kidney Diseases; Male; Methimazole; Rats; Rats, Wistar; Temperature; Time Factors | 2000 |
Effects of biliary cannulation and buthionine sulphoximine pretreatment on the nephrotoxicity of para-aminophenol in the Fischer 344 rat.
Topics: Aminophenols; Animals; Antimetabolites; Biliary Tract; Buthionine Sulfoximine; Catheterization; Glutathione; Kidney; Kidney Diseases; Liver; Magnetic Resonance Spectroscopy; Male; Methionine Sulfoximine; Protons; Rats; Rats, Inbred F344 | 1990 |
Protection against cisplatin toxicity by administration of glutathione ester.
Topics: Animals; Blood Urea Nitrogen; Buthionine Sulfoximine; Cisplatin; Creatinine; Glutathione; Kidney; Kidney Diseases; Liver; Male; Methionine Sulfoximine; Mice | 1990 |
Enhancement of cisplatin toxicity by buthionine sulfoximine, a glutathione-depleting agent, in mice.
Topics: Animals; Antimetabolites; Blood Urea Nitrogen; Buthionine Sulfoximine; Cisplatin; Drug Interactions; Glutathione; Kidney Diseases; Liver; Male; Methionine Sulfoximine; Mice; Mice, Inbred Strains | 1990 |
The deleterious effect of buthionine sulfoximine, a glutathione-depleting agent, on the cisplatin toxicity in mice.
Topics: Animals; Buthionine Sulfoximine; Cisplatin; Drug Synergism; Glutathione; Kidney; Kidney Diseases; Male; Methionine Sulfoximine; Mice; Mice, Inbred Strains | 1990 |
Nephrotoxicity of thiabendazole in mice depleted of glutathione by treatment with DL-buthionine sulphoximine.
Topics: Animals; Buthionine Sulfoximine; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Glutathione; Kidney; Kidney Diseases; Male; Methionine Sulfoximine; Mice; Oxygenases; Thiabendazole | 1990 |
Effect of buthionine sulfoximine on acute N-(3,5-dichlorophenyl)succinimide-induced nephrotoxicity in Fischer 344 rats.
Topics: Animals; Antimetabolites; Buthionine Sulfoximine; Glutathione; Kidney; Kidney Diseases; Male; Methionine Sulfoximine; Rats; Rats, Inbred F344; Succinimides; Time Factors | 1990 |
Inhibition of cisplatin-induced nephrotoxicity in rats by buthionine sulfoximine, a glutathione synthesis inhibitor.
Topics: Animals; Buthionine Sulfoximine; Carcinoma, Transitional Cell; Cisplatin; Female; gamma-Glutamyltransferase; Glutamate-Cysteine Ligase; Glutathione; Kidney; Kidney Diseases; Male; Methionine Sulfoximine; Mice; Mice, Inbred C3H; Rats; Rats, Inbred Strains; Time Factors; Urinary Bladder Neoplasms | 1987 |
Effect of buthionine sulfoximine on orthophenylphenol-induced hepato- and nephrotoxic potential in male rats.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Biphenyl Compounds; Buthionine Sulfoximine; Chemical and Drug Induced Liver Injury; Glutathione; Kidney; Kidney Diseases; Liver; Male; Methionine Sulfoximine; Organ Size; Rats; Rats, Inbred F344; Time Factors | 1988 |